SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009711
Filing Date
2022-05-12
Accepted
2022-05-12 16:32:11
Documents
110
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gls-20220331.htm   iXBRL 10-Q 3101335
2 EX-31.1 gls-ex31_1.htm EX-31.1 18911
3 EX-31.2 gls-ex31_2.htm EX-31.2 22094
4 EX-32.1 gls-ex32_1.htm EX-32.1 13557
5 EX-32.2 gls-ex32_2.htm EX-32.2 13551
  Complete submission text file 0000950170-22-009711.txt   13484185

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20220331_def.xml EX-101.DEF 471888
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gls-20220331_cal.xml EX-101.CAL 82169
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20220331.xsd EX-101.SCH 120287
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20220331_pre.xml EX-101.PRE 656129
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20220331_lab.xml EX-101.LAB 788154
104 EXTRACTED XBRL INSTANCE DOCUMENT gls-20220331_htm.xml XML 2578045
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39362 | Film No.: 22918391
SIC: 2834 Pharmaceutical Preparations